Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-22 Sale | 2024-03-26 8:10 pm | ANAPTYSBIO INC | ANAB | Faga Daniel CEO | 148,940 | $22.76 | $3,389,452 | 401,646 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 7:05 pm | ANAPTYSBIO INC | ANAB | Faga Daniel CEO | 6,866 | $21.81 | $149,747 | 951,577 (Direct) | View |
| 2021-02-02 Sale | 2021-02-03 5:09 pm | Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer | 1,340 | $194.38 | $260,469 | 94,268 (Direct) | View |
| 2021-01-07 Sale | 2021-01-08 7:15 pm | Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer | 2,625 | $216.33 | $567,854 | 23,615 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-26 Tax Withholding | 2024-03-26 8:10 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Faga Daniel CEO | 347,441 | $21.6 | 401,646 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 7:05 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Faga Daniel CEO | 17,850 | $0 | 951,577 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:52 pm | N/A 2034-01-02 | ANAPTYSBIO INC | ANAB | Faga Daniel CEO | 518,330 | $0 | 518,330 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 7:04 pm | N/A 2033-01-05 | ANAPTYSBIO INC | ANAB | Faga Daniel Interim CEO | 266,300 | $0 | 266,300 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 4:48 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Faga Daniel Interim CEO | 887,043 | $0 | 887,043 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 4:43 pm | N/A 2032-02-09 | ANAPTYSBIO INC | ANAB | Faga Daniel Director | 9,200 | $0 | 9,200 (Direct) | View |
| 2021-11-26 Option Award | 2021-11-30 5:26 pm | N/A 2031-11-25 | ANAPTYSBIO INC | ANAB | Faga Daniel Director | 13,321 | $0 | 13,321 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-03 5:09 pm | N/A 2030-01-05 | Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer | 1,340 | $0 | 94,268 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-03 5:09 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer | 1,340 | $114.33 | 94,268 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 6:14 pm | N/A 2031-01-14 | Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer | 18,002 | $0 | 41,617 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 9:07 pm | N/A 2030-01-05 | Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer | 91,210 | $0 | 91,210 (Direct) | View |
| 2019-12-17 Equity Swap | 2019-12-17 4:42 pm | N/A N/A | Spark Therapeutics Inc. | ONCE | Faga Daniel Chief Business Officer | 38,828 | $114.5 | 0 (Direct) | View |
| 2019-12-17 Disposition | 2019-12-17 4:42 pm | N/A 2029-01-15 | Spark Therapeutics Inc. | ONCE | Faga Daniel Chief Business Officer | 146,750 | $0 | 0 (Direct) | View |